Cargando…

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures

Urotensin-II was originally isolated from the goby urophysis in the 1960s as a vasoactive peptide with a prominent role in cardiovascular homeostasis. The identification of human isoform of urotensin-II and its specific UT receptor by Ames et al. in 1999 led to investigating the putative role of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merlino, Francesco, Di Maro, Salvatore, Munaim Yousif, Ali, Caraglia, Michele, Grieco, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596952/ https://www.ncbi.nlm.nih.gov/pubmed/23533711 http://dx.doi.org/10.1155/2013/979016

Ejemplares similares

Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells
por: Zappavigna, Silvia, et al.
Publicado: (2019)

Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion
por: Franco, Renato, et al.
Publicado: (2014)

Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes
por: Yousif, Ali Munaim, et al.
Publicado: (2015)

Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout
por: Lancien, Frédéric, et al.
Publicado: (2017)

A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands
por: di Villa Bianca, Roberta d’Emmanuele, et al.
Publicado: (2015)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout
por: Vanegas, Gilmer, et al.
Publicado: (2015)

Endogenous Urotensin II Selectively Modulates Erectile Function through eNOS
por: d'Emmanuele di Villa Bianca, Roberta, et al.
Publicado: (2012)

Urotensin II in cardiovascular regulation
por: Russell, Fraser D
Publicado: (2008)

Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands
por: Nassour, Hassan, et al.
Publicado: (2021)

Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells
por: Park, Sung Lyea, et al.
Publicado: (2013)

Urotensin II in Invertebrates: From Structure to Function in Aplysia californica
por: Romanova, Elena V., et al.
Publicado: (2012)

Urotensin II-related peptides, Urp1 and Urp2, control zebrafish spine morphology
por: Bearce, Elizabeth A, et al.
Publicado: (2022)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011)

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014)

Urotensin-II: More Than a Mediator for Kidney
por: Balat, Ayşe, et al.
Publicado: (2012)

Blockade of Urotensin II Receptor Prevents Vascular Dysfunction
por: Kim, Young-Ae, et al.
Publicado: (2016)

Role of Urotensin-II in Saphenous Vein Graft Disease
por: Tüysüz, Mehmet Erin, et al.
Publicado: (2020)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Urotensin II Exerts Pressor Effects By Stimulating Renin And Aldosterone Synthase Gene Expression
por: Caroccia, Brasilina, et al.
Publicado: (2017)

The value of urotensin II in patients with left-sided rheumatic valvular regurgitation
por: Elmadbouh, Ibrahim, et al.
Publicado: (2017)

The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification
por: Albanese, Isabella, et al.
Publicado: (2016)

Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies
por: Ghatage, Trupti, et al.
Publicado: (2021)

Urotensin II levels in patients with chronic kidney disease and kidney transplants
por: Hursitoglu, Mehmet, et al.
Publicado: (2012)

A closer look at the role of urotensin II in the metabolic syndrome
por: Barrette, Pierre-Olivier, et al.
Publicado: (2012)

Irisin levels are associated with urotensin II levels in diabetic patients
por: He, Wan-Yu, et al.
Publicado: (2015)

Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma
por: Portnoy, Alison, et al.
Publicado: (2013)

The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
por: Simunovic, Marko, et al.
Publicado: (2022)

Urotensin II level is elevated in inflammatory bowel disease patients
por: Zhang, Yan, et al.
Publicado: (2022)

Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction
por: Ogawa, Akiko, et al.
Publicado: (2023)

Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor
por: Giorgioni, Gianfabio, et al.
Publicado: (2022)

Novel α-MSH Peptide Analogues with Broad Spectrum Antimicrobial Activity
por: Grieco, Paolo, et al.
Publicado: (2013)

The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer
por: Balakan, Ozan, et al.
Publicado: (2014)

The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
por: ZHAO, JUAN, et al.
Publicado: (2013)

Urotensin-II System in Genetic Control of Blood Pressure and Renal Function
por: Debiec, Radoslaw, et al.
Publicado: (2013)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

Urotensin II promotes aldosterone expression in rat aortic adventitial fibroblasts
por: Li, Jun, et al.
Publicado: (2018)

Expression of urotensin II is associated with placental autophagy in patients with severe preeclampsia
por: Pan, Ya-Jing, et al.
Publicado: (2018)

Serum Urotensin II Levels Are Elevated in Patients with Obstructive Sleep Apnea
por: Mihovilovic, Ante, et al.
Publicado: (2023)

The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells
por: Ingangi, Vincenzo, et al.
Publicado: (2016)

Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α-Synuclein Mouse Models of Parkinson’s Disease
por: Kilpeläinen, Tommi P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gnpm0esmlv6n1l14bm11iturf2